Avidity Biosciences (NASDAQ:RNA) Given Buy Rating at HC Wainwright
Avidity Biosciences (NASDAQ:RNA – Get Free Report)‘s stock had its “buy” rating reiterated by equities research analysts at HC Wainwright in a research note issued on Monday,Benzinga reports. They currently have a $72.00 price objective on the biotechnology company’s stock. HC Wainwright’s target price would suggest a potential upside of 136.22% from the stock’s previous […]
Avidity Biosciences (NASDAQ:RNA – Get Free Report)‘s stock had its “buy” rating reiterated by equities research analysts at HC Wainwright in a research note issued on Monday,Benzinga reports. They currently have a $72.00 price objective on the biotechnology company’s stock. HC Wainwright’s target price would suggest a potential upside of 136.22% from the stock’s previous […]
